litlas
ログインアカウント作成

Richard J. Wallace

1971–2025 年に発表

別表記
RICHARD J. WALLACE
214
論文数
32,954
被引用数
96
h 指数
167
i10 指数

被引用数

Richard J. Wallace の年別被引用数1972 年: 被引用 1 件1975 年: 被引用 2 件1976 年: 被引用 3 件1977 年: 被引用 4 件1979 年: 被引用 3 件1980 年: 被引用 3 件1981 年: 被引用 5 件1982 年: 被引用 9 件1983 年: 被引用 15 件1984 年: 被引用 11 件1985 年: 被引用 15 件1986 年: 被引用 15 件1987 年: 被引用 13 件1988 年: 被引用 18 件1989 年: 被引用 15 件1990 年: 被引用 33 件1991 年: 被引用 19 件1992 年: 被引用 45 件1993 年: 被引用 58 件1994 年: 被引用 88 件1995 年: 被引用 79 件1996 年: 被引用 92 件1997 年: 被引用 117 件1998 年: 被引用 92 件1999 年: 被引用 90 件2000 年: 被引用 134 件2001 年: 被引用 145 件2002 年: 被引用 190 件2003 年: 被引用 185 件2004 年: 被引用 191 件2005 年: 被引用 138 件2006 年: 被引用 265 件2007 年: 被引用 189 件2008 年: 被引用 195 件2009 年: 被引用 187 件2010 年: 被引用 182 件2011 年: 被引用 145 件2012 年: 被引用 269 件2013 年: 被引用 196 件2014 年: 被引用 245 件2015 年: 被引用 247 件2016 年: 被引用 319 件2017 年: 被引用 303 件2018 年: 被引用 264 件2019 年: 被引用 819 件2020 年: 被引用 747 件2021 年: 被引用 634 件2022 年: 被引用 496 件2023 年: 被引用 363 件2024 年: 被引用 558 件2025 年: 被引用 222 件2026 年: 被引用 8 件1973〜1974 年は被引用が無いため表示していません1978 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,647 件、この内訳の 28.4%フランス: 引用元論文 380 件、この内訳の 6.5%イギリス: 引用元論文 366 件、この内訳の 6.3%中国: 引用元論文 255 件、この内訳の 4.4%カナダ: 引用元論文 239 件、この内訳の 4.1%ドイツ: 引用元論文 229 件、この内訳の 3.9%イタリア: 引用元論文 197 件、この内訳の 3.4%スペイン: 引用元論文 193 件、この内訳の 3.3%日本: 引用元論文 189 件、この内訳の 3.3%オランダ: 引用元論文 187 件、この内訳の 3.2%韓国: 引用元論文 183 件、この内訳の 3.2%オーストラリア: 引用元論文 155 件、この内訳の 2.7%
0%28.4%その他 27.3%

機関

分野

  • Medicine67.1%
  • Computer Science15%
  • Biochemistry, Genetics and Molecular Biology6.4%
  • Immunology and Microbiology3.3%
  • Neuroscience1.9%
  • Environmental Science1.6%
  • その他4.7%

トピック

  • Mycobacterium research and diagnosis17.2%
  • Tuberculosis Research and Epidemiology12.7%
  • Infectious Diseases and Mycology6.2%
  • Constraint Satisfaction and Optimization4.4%
  • Actinomycetales infections and treatment2.4%
  • Antibiotic Resistance in Bacteria2.2%
  • その他54.9%

共著者

全論文

検索で開く
  1. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

    著者: David E. Griffith, Timothy R. Aksamit, Barbara A. Brown‐Elliott, Antonino Catanzaro, Charles L. Daley, Fred M. Gordin, Steven M. Holland, Robert Horsburgh, Gwen A. Huitt, Michael F. Iademarco, Michael D. Iseman, Kenneth N. Olivier, Stephen J. Ruoss, C. Fordham von Reyn, Richard J. Wallace, Kevin Winthrop - American Journal of Respiratory and Critical Care Medicine 2007 被引用: 6,107

  2. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

    著者: Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. Wallace, C. Andréjak, Erik C. Böttger, Jan Brożek, David E. Griffith, Lorenzo Guglielmetti, Gwen A. Huitt, Shandra L. Knight, Philip Leitman, Theodore K. Marras, Kenneth N. Olivier, Miguel Santín, Jason E. Stout, Enrico Tortoli, Jakko van Ingen, Dirk Wagner, Kevin Winthrop - Clinical Infectious Diseases 2020 被引用: 888

  3. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study

    著者: David E. Griffith, Gina Eagle, Rachel Thomson, Timothy R. Aksamit, Naoki Hasegawa, Kozo Morimoto, Doreen Addrizzo‐Harris, Anne E. O’Donnell, Theodore K. Marras, Patrick A. Flume, Michael R. Loebinger, Lucy Morgan, Luigi Ruffo Codecasa, Adam T. Hill, Stephen J. Ruoss, Jae‐Joon Yim, Felix C. Ringshausen, Stephen K. Field, Julie V. Philley, Richard J. Wallace, Jakko van Ingen, Chris Coulter, James Nezamis, Kevin Winthrop - American Journal of Respiratory and Critical Care Medicine 2018 被引用: 343

  4. A Novel Gene, erm (41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae

    著者: Kevin A. Nash, Barbara A. Brown‐Elliott, Richard J. Wallace - Antimicrobial Agents and Chemotherapy 2009 被引用: 644

  5. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

    著者: R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman, Charles L. Daley, Jean‐Louis Herrmann, Jerry A. Nick, Peadar G. Noone, Diana Bilton, Paul A. Corris, Ronald L. Gibson, Sarah E. Hempstead, Karsten Koetz, Kathryn A. Sabadosa, Isabelle Sermet‐Gaudelus, Alan R Smyth, Jakko van Ingen, Richard J. Wallace, Kevin Winthrop, Bruce C. Marshall, Charles Haworth - Thorax 2015 被引用: 470

  6. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases

    著者: Christoph Lange, Erik C. Böttger, Emmanuelle Cambau, David E. Griffith, Lorenzo Guglielmetti, Jakko van Ingen, Shandra L. Knight, Theodore K. Marras, Kenneth N. Olivier, Miguel Santín, Jason E. Stout, Enrico Tortoli, Dirk Wagner, Kevin Winthrop, Charles L. Daley, Christoph Lange, Claire Andréjak, Erik C. Böttger, Emmanuelle Cambau, David E. Griffith, Lorenzo Guglielmetti, Jakko van Ingen, Shandra L. Knight, Philip Leitman, Theodore K. Marras, Kenneth N. Olivier, Miguel Santín, Jason E. Stout, Enrico Tortoli, Dirk Wagner, Richard J. Wallace, Kevin Winthrop, Charles L. Daley - The Lancet Infectious Diseases 2022 被引用: 160

  7. Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular Taxonomy

    著者: Barbara A. Brown‐Elliott, June M. Brown, Patricia S. Conville, Richard J. Wallace - Clinical Microbiology Reviews 2006 被引用: 1,104

  8. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

    著者: R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman, Charles L. Daley, Jean‐Louis Herrmann, Jerry A. Nick, Peadar G. Noone, Diana Bilton, Paul A. Corris, Ronald L. Gibson, Sarah E. Hempstead, Karsten Koetz, Kathryn A. Sabadosa, Isabelle Sermet‐Gaudelus, Alan R Smyth, Jakko van Ingen, Richard J. Wallace, Kevin Winthrop, Bruce C. Marshall, Charles Haworth - Thorax 2015 被引用: 460

  9. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

    著者: Jakko van Ingen, Timothy R. Aksamit, C. Andréjak, Erik C. Böttger, Emmanuelle Cambau, Charles L. Daley, David E. Griffith, Lorenzo Guglielmetti, Steven M. Holland, Gwen A. Huitt, Won‐Jung Koh, Christoph Lange, Philip Leitman, Theodore K. Marras, Kozo Morimoto, Kenneth N. Olivier, Miguel Santín, Jason E. Stout, Rachel Thomson, Enrico Tortoli, Richard J. Wallace, Kevin Winthrop, Dirk Wagner - European Respiratory Journal 2018 被引用: 263

  10. Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial

    著者: Kevin Winthrop, Patrick A. Flume, Rachel Thomson, Kevin C. Mange, Dayton W. Yuen, Monika Ciesielska, Kozo Morimoto, Stephen J. Ruoss, Luigi Ruffo Codecasa, Jae‐Joon Yim, Theodore K. Marras, Jakko van Ingen, Richard J. Wallace, Barbara A. Brown‐Elliott, Chris Coulter, David E. Griffith - Annals of the American Thoracic Society 2020 被引用: 73

  11. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease

    著者: Kenneth N. Olivier, David E. Griffith, Gina Eagle, John P. McGinnis, Liza Micioni, Keith Liu, Charles L. Daley, Kevin Winthrop, Stephen J. Ruoss, Doreen Addrizzo‐Harris, Patrick A. Flume, Daniel Dorgan, Matthias Salathé, Barbara A. Brown‐Elliott, Renu Gupta, Richard J. Wallace - American Journal of Respiratory and Critical Care Medicine 2016 被引用: 246

  12. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes

    著者: Gail L. Woods, Barbara A. Brown‐Elliott, Patricia S. Conville, Edward Desmond, Geraldine S. Hall, Grace Lin, Gaby E. Pfyffer, John C. Ridderhof, Salman H. Siddiqi, Richard J. Wallace, Nancy G. Warren, Frank G. Witebsky - 2011 被引用: 1,152

  13. Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov.

    著者: Enrico Tortoli, Thomas A. Kohl, Barbara A. Brown‐Elliott, Alberto Trovato, Sylvia Cardoso Leão, María Jesús García García, Sruthi Vasireddy, Christine Y. Turenne, David E. Griffith, Julie V. Philley, Rossella Baldan, Silvia Campana, Lisa Cariani, Carla Colombo, Giovanni Taccetti, Antonio Teri, Stefan Niemann, Richard J. Wallace, Daniela María Cirillo - INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY 2016 被引用: 231

  14. Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease

    著者: David E. Griffith, Barbara A. Brown‐Elliott, Brett Langsjoen, Yansheng Zhang, Xi Pan, William M. Girard, Kenwyn G. Nelson, James A. Caccitolo, Julio Álvarez, Sara Shepherd, Rebecca W. Wilson, Edward A. Graviss, Richard J. Wallace - American Journal of Respiratory and Critical Care Medicine 2006 被引用: 356

  15. Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease

    著者: Richard J. Wallace, Barbara A. Brown‐Elliott, Steven G. McNulty, Julie V. Philley, Jessica Killingley, Rebecca W. Wilson, Deanna York, Sara Shepherd, David E. Griffith - CHEST Journal 2014 被引用: 349

  16. In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria

    著者: Barbara A. Brown‐Elliott, Richard J. Wallace - Antimicrobial Agents and Chemotherapy 2020 被引用: 66

  17. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease

    著者: Julie V. Philley, Richard J. Wallace, Jeana L. Benwill, Varsha Taskar, Barbara A. Brown‐Elliott, Foram Thakkar, Timothy R. Aksamit, David E. Griffith - CHEST Journal 2015 被引用: 221

  18. Same meat, different gravy: ignore the new names of mycobacteria

    著者: Enrico Tortoli, Barbara A. Brown‐Elliott, James D. Chalmers, Daniela María Cirillo, Charles L. Daley, Stefan Emler, R. Andrés Floto, María José García Sánchez, Wouter Hoefsloot, Won‐Jung Koh, Christoph Lange, Michael R. Loebinger, Florian P. Maurer, Kozo Morimoto, Stefan Niemann, Elvira Richter, Christine Y. Turenne, Ravikiran Vasireddy, Sruthi Vasireddy, Dirk Wagner, Richard J. Wallace, Nancy L. Wengenack, Jakko van Ingen - European Respiratory Journal 2019 被引用: 72

  19. Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease

    著者: Sarah Siegel, David E. Griffith, Julie V. Philley, Barbara A. Brown‐Elliott, Amanda E. Brunton, Peter E. Sullivan, Cristina Fuss, Luke Strnad, Richard J. Wallace, Kevin Winthrop - CHEST Journal 2023 被引用: 23

  20. Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria

    著者: Barbara A. Brown‐Elliott, Richard J. Wallace - Clinical Microbiology Reviews 2002 被引用: 909

  21. Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria

    著者: Barbara A. Brown‐Elliott, Kevin A. Nash, Richard J. Wallace - Clinical Microbiology Reviews 2012 被引用: 526

  22. Respiratory Outbreak of Mycobacterium abscessus Subspecies massiliense in a Lung Transplant and Cystic Fibrosis Center

    著者: Moira L. Aitken, Ajit P. Limaye, Paul S. Pottinger, Estella Whimbey, Christopher H. Goss, Mark R. Tonelli, Gerard A. Cangelosi, M. Ashworth Dirac, Kenneth N. Olivier, Barbara A. Brown‐Elliott, Steven G. McNulty, Richard J. Wallace - American Journal of Respiratory and Critical Care Medicine 2012 被引用: 307

  23. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections

    著者: Richard J. Wallace, Gary Dukart, Barbara A. Brown‐Elliott, David E. Griffith, Ernesto G. Scerpella, Ben G. Marshall - Journal of Antimicrobial Chemotherapy 2014 被引用: 184

  24. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus

    著者: Richard J. Wallace, A Meier, Barbara A. Brown, Y Zhang, Peter Sander, G O Onyi, E C Böttger - Antimicrobial Agents and Chemotherapy 1996 被引用: 287